Skip to main content
Clinical Trials/NL-OMON38693
NL-OMON38693CompletedNot Applicable

DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING DOSES AND THE EFFECT OF FOOD ON ORAL WCK 4873 IN HEALTHY ADULT VOLUNTEERS - WCK 4873 Phase 1 SAD FE Study

Wockhardt Bio AG0 sites78 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
78

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • healthy male or female
  • 18 - 65 years inclusive
  • BMI 18.0 - 30.0 kg/m2 inclusive
  • non-smoker

Exclusion Criteria

  • Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS.
  • Participation in another drug study within 60 days prior to randomization.
  • Any donation of blood(products) or significant blood loss within 60 days prior to drug administration

Investigators

Similar Trials